Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BREAST-CARCINOMA CELLS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 175 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Roy, KK; Sausville, EA
      Early development of cyclin dependent kinase modulators

      CURRENT PHARMACEUTICAL DESIGN
    2. Decker, RH; Dai, Y; Grant, S
      The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway

      CELL DEATH AND DIFFERENTIATION
    3. Lademann, U; Kallunki, T; Jaattela, M
      A20 zinc finger protein inhibits TNF-induced apoptosis and stress responseearly in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins

      CELL DEATH AND DIFFERENTIATION
    4. Wang, CG; Fu, MF; Mani, S; Wadler, S; Senderowicz, AM; Pestell, RG
      Histone acetylation and the cell-cycle in cancer

      FRONTIERS IN BIOSCIENCE
    5. Barcellos-Hoff, MH
      It takes a tissue to make a tumor: Epigenetics, cancer and the microenvironment

      JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
    6. Rapoport, AP; Simons-Evelyn, M; Chen, T; Sidell, R; Luhowskyj, S; Rosell, K; Obrig, T; Hicks, D; Hinkle, PM; Nahm, M; Insel, RA; Abboud, CN
      Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes

      BLOOD CELLS MOLECULES AND DISEASES
    7. Jung, CP; Motwani, MV; Schwartz, GK
      Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotidereductase M2 subunit

      CLINICAL CANCER RESEARCH
    8. Shapiro, GI; Supko, JG; Patterson, A; Lynch, C; Lucca, J; Zacarola, PF; Muzikansky, A; Wright, JJ; Lynch, TJ; Rollins, BJ
      A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    9. Kawakami, K; Kawakami, M; Puri, RK
      Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy

      CRITICAL REVIEWS IN IMMUNOLOGY
    10. Soni, R; Chaudhuri, B
      Cell cycle arrest mediated by a pyridopyrimidine is not abrogated by over-expression of Bcl-2 and cyclin D1

      INTERNATIONAL JOURNAL OF ONCOLOGY
    11. Senderowicz, AM
      Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies

      LEUKEMIA
    12. Hughes, RC
      Galectins as modulators of cell adhesion

      BIOCHIMIE
    13. Carloni, V; Mazzocca, A; Pantaleo, P; Cordella, C; Laffi, G; Gentilini, P
      The integrin, alpha 6 beta 1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells

      HEPATOLOGY
    14. Kauppila, S; Jukkola, A; Melkko, J; Risteli, L; Turpeeniemi-Hujanen, T; Vuorinen, K; Risteli, J
      Aminoterminal propeptide of the alpha 1-homotrimer variant of human type Iprocollagen (hotPINP) in malignant pleural effusion

      ANTICANCER RESEARCH
    15. Brockhoff, G; Heiss, P; Schlegel, J; Hofstaedter, F; Knuechel, R
      Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells

      CYTOMETRY
    16. Fukuoka, K; Usuda, J; Iwamoto, Y; Fukumoto, H; Nakamura, T; Yoneda, T; Narita, N; Saijo, N; Nishio, K
      Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells

      INVESTIGATIONAL NEW DRUGS
    17. Hassan, P; Fergusson, D; Grant, KM; Mottram, JC
      The CRK3 protein kinase is essential for cell cycle progression of Leishmania Mexicana

      MOLECULAR AND BIOCHEMICAL PARASITOLOGY
    18. Rossini, GP; Sgarbi, N; Malaguti, C
      The toxic responses induced by okadaic acid involve processing of multiplecaspase isoforms

      TOXICON
    19. Barcellos-Hoff, MH; Brooks, AL
      Extracellular signaling through the microenvironment: A hypothesis relating carcinogenesis, bystander effects, and genomic instability

      RADIATION RESEARCH
    20. Wang, SY; Yang, KW; Hsu, YT; Chang, CL; Yang, YC
      The differential inhibitory effects of genistein on the growth of cervicalcancer cells in vitro

      NEOPLASMA
    21. Medina, MA
      Glutamine and cancer

      JOURNAL OF NUTRITION
    22. Chakrabarty, S; Liu, BR; Rajagopal, S
      Disruption of transforming growth factor beta-regulated laminin receptor function by expression of antisense laminin, a chain RNA in human colon cancer cells

      JOURNAL OF CELLULAR PHYSIOLOGY
    23. Seewaldt, VL; Mrozek, K; Sigle, R; Dietze, EC; Heine, K; Hockenbery, DM; Hobbs, KB; Caldwell, LE
      Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis

      JOURNAL OF CELL BIOLOGY
    24. Dow, R; Hendley, J; Pirkmaier, A; Musgrove, EA; Germain, D
      Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2

      JOURNAL OF BIOLOGICAL CHEMISTRY
    25. Brodt, P; Fallavollita, L; Khatib, AM; Samani, AA; Zhang, DL
      Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit

      JOURNAL OF BIOLOGICAL CHEMISTRY
    26. Chao, SH; Price, DH
      Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo

      JOURNAL OF BIOLOGICAL CHEMISTRY
    27. Yoon, SO; Kim, MM; Chung, AS
      Inhibitory effect of selenite on invasion of HT1080 tumor cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    28. Cottin, V; Van Linden, AA; Riches, DWH
      Phosphorylation of the tumor necrosis factor receptor CD120a (p55) recruits Bcl-2 and protects against apoptosis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    29. Li, WW; Fan, JG; Bertino, JR
      Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by ravopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity

      CANCER RESEARCH
    30. Casagrande, F; Darbon, JM
      Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1

      BIOCHEMICAL PHARMACOLOGY
    31. Kaubisch, A; Schwartz, GK
      Cyclin-dependent kinase and protein kinase C inhibitors: A novel class of antineoplastic agents in clinical development

      CANCER JOURNAL
    32. Liu, FT
      Galectins: A new family of regulators of inflammation

      CLINICAL IMMUNOLOGY
    33. Friedl, P; Brocker, EB
      The biology of cell locomotion within three-dimensional extracellular matrix

      CELLULAR AND MOLECULAR LIFE SCIENCES
    34. Mani, S; Wang, CG; Wu, KM; Francis, R; Pestell, R
      Cyclin-dependent kinase inhibitors: novel anticancer agents

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    35. Kelland, LR
      Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    36. Manna, SK; Haridas, V; Aggarwal, BB
      Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappa B, activation protein-1, and c-Jun N-terminal kinase

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    37. Innocenti, F; Stadler, WM; Iyer, L; Ramirez, J; Vokes, EE; Ratain, MJ
      Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea

      CLINICAL CANCER RESEARCH
    38. Ciardiello, F; Caputo, R; Bianco, R; Damiano, V; Pomatico, G; De Placido, S; Bianco, AR; Tortora, G
      Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor

      CLINICAL CANCER RESEARCH
    39. Green, DW; Roh, H; Pippin, J; Drebin, JA
      Antisense oligonucleotides: An evolving technology for the modulation of gene expression in human disease

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    40. Belkin, AM; Stepp, MA
      Integrins as receptors for laminins

      MICROSCOPY RESEARCH AND TECHNIQUE
    41. Gescher, A
      Staurosporine analogues - pharmacological toys or useful antitumour agents?

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    42. Li, YW; Chinni, SR; Senderowicz, AM; Sarkar, FH
      Induction of growth inhibition and apoptosis in prostate cancer cells by flavopiridol

      INTERNATIONAL JOURNAL OF ONCOLOGY
    43. Owen-Schaub, L; Chan, H; Cusack, JC; Roth, J; Hill, LL
      Fas and Fas ligand interactions in malignant disease (Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    44. Pallares-Trujillo, J; Lopez-Soriano, FJ; Argiles, JM
      Lipids: A key role in multidrug resistance? (Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    45. Senderowicz, AM
      Small molecule modulators of cyclin-dependent kinases for cancer therapy

      ONCOGENE
    46. Panigone, S; Debernardi, S; Taya, Y; Fontanella, E; Airoldi, R; Delia, D
      pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide

      ONCOGENE
    47. Colic, M; Pavelic, K
      Molecular mechanisms of anticancer activity of natural dietetic products

      JOURNAL OF MOLECULAR MEDICINE-JMM
    48. Tsai, CM; Chang, KT; Li, L; Perng, RP; Yang, LY
      Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    49. Jiang, C; Ganther, H; Lu, JX
      Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: Implications for angiogenic switch regulation

      MOLECULAR CARCINOGENESIS
    50. Stadler, WM; Vogelzang, NJ; Amato, R; Sosman, J; Taber, D; Liebowitz, D; Vokes, EE
      Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: A University of Chicago phase II consortium study

      JOURNAL OF CLINICAL ONCOLOGY
    51. Damiens, E; Meijer, L
      Chemical inhibitors of cyclin-dependent kinases: preclinical and clinical studies.

      PATHOLOGIE BIOLOGIE
    52. Lu, K; Shih, C; Teicher, BA
      Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    53. Liberto, M; Cobrinik, D
      Growth factor-dependent induction of p21(CIP1) by the green tea by polyphenol, epigallocatechin gallate

      CANCER LETTERS
    54. Angelucci, A; D'Ascenzo, S; Festuccia, C; Gravina, GL; Bologna, M; Dolo, V; Pavan, A
      Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines

      CLINICAL & EXPERIMENTAL METASTASIS
    55. Hyder, SM; Stancel, GM
      Regulation of VEGF in the reproductive tract by sex-steroid hormones

      HISTOLOGY AND HISTOPATHOLOGY
    56. Albanese, J; Dainiak, N
      Ionizing radiation alters Fas antigen ligand at the cell surface and on exfoliated plasma membrane-derived vesicles: Implications for apoptosis and intercellular signaling

      RADIATION RESEARCH
    57. Henriet, P; Zhong, ZD; Brooks, PC; Weinberg, KI; DeClerck, YA
      Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27(KIP1)

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    58. Li, XK; Motwani, M; Tong, W; Bornmann, W; Schwartz, GK
      Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells

      MOLECULAR PHARMACOLOGY
    59. Sielecki, TM; Boylan, JF; Benfield, PA; Trainor, GL
      Cyclin-dependent kinase inhibitors: Useful targets in cell cycle regulation

      JOURNAL OF MEDICINAL CHEMISTRY
    60. Ram, TG; Hosick, HL; Ethier, SP
      Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells

      JOURNAL OF CELLULAR PHYSIOLOGY
    61. Wagner, PD; Vu, ND
      Phosphorylation of geranyl and farnesyl pyrophosphates by Nm23 proteins/nucleoside diphosphate kinases

      JOURNAL OF BIOLOGICAL CHEMISTRY
    62. Chao, SH; Fujinaga, K; Marion, JE; Taube, R; Sausville, EA; Senderowicz, AM; Peterlin, BM; Price, DH
      Flavopiridol inhibits P-TEFb and blocks HIV-1 replication

      JOURNAL OF BIOLOGICAL CHEMISTRY
    63. Darbon, JM; Penary, M; Escalas, N; Casagrande, F; Goubin-Gramatica, F; Baudouin, C; Ducommun, B
      Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    64. Fukuoka, K; Yamagishi, T; Ichihara, T; Nakaike, S; Iguchi, K; Yamada, Y; Fukumoto, H; Yoneda, T; Samata, K; Ikeya, H; Nanaumi, K; Hirayama, N; Narita, N; Saijo, N; Nishio, K
      Mechanism of action of aragusterol A (YTA0040), a potent anti-tumor marinesteroid targeting the G(1) phase of the cell cycle

      INTERNATIONAL JOURNAL OF CANCER
    65. Ferte, J
      Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    66. Ciardiello, F
      Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents

      DRUGS
    67. Kanai, T; Watanabe, M; Hayashi, A; Nakazawa, A; Yajima, T; Okazawa, A; Yamazaki, M; Ishii, H; Hibi, T
      Regulatory effect of interleukin-4 and interleukin-13 on colon cancer celladhesion

      BRITISH JOURNAL OF CANCER
    68. Jiang, C; Agarwal, R; Lu, JX
      Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: Inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    69. Senderowicz, AM; Sausville, EA
      Preclinical and clinical development of cyclin-dependent kinase modulators

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    70. Blanck, G
      HLA class II expression in human tumor lines

      MICROBES AND INFECTION
    71. Youn, J; Lynes, MA
      Metallothionein-induced suppression of cytotoxic T lymphocyte function: Animportant immunoregulatory control

      TOXICOLOGICAL SCIENCES
    72. Doman, RK; Perez, M; Donato, NJ
      JNK and p53 stress signaling cascades are altered in MCF-7 cells resistantto tumor necrosis factor-mediated apoptosis

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    73. Tsuruda, L; Hou, YT; Penning, T
      Stable transfection of dihydrodiol dehydrogenase in MCF-7 breast carcinomacells promotes polycyclic aromatic hydrocarbon-o-quinone formation which leads to cell death

      POLYCYCLIC AROMATIC COMPOUNDS
    74. Wen, XY; Stewart, AS; Sooknanan, RR; Henderson, G; Hawley, TS; Reimold, AM; Glimcher, LH; Baumann, H; Malek, LT; Hawley, RG
      Identification of c-myc promoter-binding protein and X-box binding proteinI as interleukin-6 target genes in human multiple myeloma cells.

      INTERNATIONAL JOURNAL OF ONCOLOGY
    75. Stimpfl, M; Schmid, BC; Obermair, A; Tong, D; Schiebel, I; Gitsch, G; Leodolter, S; Zeillinger, R
      Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood

      ONCOLOGY RESEARCH
    76. Ito, K; Okamoto, I; Araki, N; Kawano, Y; Nakao, M; Fujiyama, S; Tomita, K; Mimori, T; Saya, H
      Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts

      ONCOGENE
    77. Rao, RN; Stamm, NB; Otto, K; Kovacevic, S; Watkins, SA; Rutherford, P; Lemke, S; Cocke, K; Beckmann, RP; Houck, K; Johnson, D; Skidmore, BJ
      Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene

      ONCOGENE
    78. Ameyar, M; Shatrov, V; Bouquet, C; Capoulade, C; Cai, ZZ; Stancou, R; Badie, C; Haddada, H; Chouaib, S
      Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb

      ONCOGENE
    79. Zhu, X; Pattenden, S; Bremner, R
      PRB is required for interferon-gamma-induction of the MHC class II A beta gene

      ONCOGENE
    80. Brakebusch, C; Wennerberg, K; Krell, HW; Weidle, UH; Sallmyr, A; Johansson, S; Fassler, R
      beta 1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts

      ONCOGENE
    81. Jiang, C; Jiang, WQ; Ip, C; Ganther, H; Lu, LX
      Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake

      MOLECULAR CARCINOGENESIS
    82. Martelli, AM; Sang, NL; Borgatti, P; Capitani, S; Neri, LM
      Multiple biological responses activated by nuclear protein kinase C

      JOURNAL OF CELLULAR BIOCHEMISTRY
    83. Chien, M; Astumian, M; Liebowitz, D; Rinker-Schaeffer, C; Stadler, WM
      In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    84. Jiang, SY; Lin, DY; Shyu, RY; Reichert, U; Yeh, MY
      The RAR gamma selective agonist CD437 inhibits gastric cell growth throughthe mechanism of apoptosis

      CANCER LETTERS
    85. Gopalakrishna, R; Gundimeda, U; Fontana, JA; Clarke, R
      Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status

      CANCER LETTERS
    86. Ma, YJ; Hill, DF; Creswick, KE; Costa, ME; Cornea, A; Lioubin, MN; Plowman, GD; Ojeda, SR
      Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development

      JOURNAL OF NEUROSCIENCE
    87. Sintich, SM; Steinberg, J; Kozlowski, JM; Lee, C; Pruden, S; Sayeed, S; Sensibar, JA
      Cytotoxic sensitivity to tumor necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin)

      PROSTATE
    88. Dolo, V; D'Ascenzo, S; Violini, S; Pompucci, L; Festuccia, C; Ginestra, A; Vittorelli, ML; Canevari, S; Pavan, A
      Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro

      CLINICAL & EXPERIMENTAL METASTASIS
    89. Kumeda, SI; Deguchi, A; Toi, M; Omura, S; Umezawa, K
      Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells

      ANTICANCER RESEARCH
    90. Ginestra, A; Miceli, D; Dolo, V; Romano, FM; Vittorelli, ML
      Membrane vesicles in ovarian cancer fluids: A new potential marker

      ANTICANCER RESEARCH
    91. Shen, F; Xue, XJ; Weber, G
      Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells

      ANTICANCER RESEARCH
    92. Han, JA; Park, SC
      Reduction of transglutaminase 2 expression is associated with an inductionof drug sensitivity in the PC-14 human lung cancer cell line

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    93. Oosterlaken-Dijksterhuis, MA; Kwant, MM; Slob, A; Hellmen, E; Mol, JA
      IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumor cell line CMT-U335

      BREAST CANCER RESEARCH AND TREATMENT
    94. Otero, ADS; Doyle, MB; Hartsough, MT; Steeg, PS
      Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization ofmuscarinic potassium current

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    95. Sausville, EA; Zaharevitz, D; Gussio, R; Meijer, L; Louarn-Leost, M; Kunick, C; Schultz, R; Lahusen, T; Headlee, D; Stinson, S; Arbuck, SG; Senderowicz, A
      Cyclin-dependent kinases: Initial approaches to exploit a novel therapeutic target

      PHARMACOLOGY & THERAPEUTICS
    96. Go, V; Garey, J; Wolff, MS; Pogo, BGT
      Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line

      ENVIRONMENTAL HEALTH PERSPECTIVES
    97. Penichet, ML; Challita, PM; Shin, SU; Sampogna, SL; Rosenblatt, JD; Morrison, SL
      In vivo properties of three human HER2/neu-expressing murine cell lines inimmunocompetent mice

      LABORATORY ANIMAL SCIENCE
    98. Shapiro, GI; Harper, JW
      Anticancer drug targets: cell cycle and checkpoint control

      JOURNAL OF CLINICAL INVESTIGATION
    99. Klinowska, TCM; Soriano, JV; Edwards, GM; Oliver, JM; Valentijn, AJ; Montesano, R; Streuli, CH
      Laminin and beta 1 integrins are crucial for normal mammary gland development in the mouse

      DEVELOPMENTAL BIOLOGY
    100. Bjornland, K; Winberg, JO; Odegaard, OT; Hovig, E; Loennechen, T; Aasen, AO; Fodstad, O; Maelandsmo, GM
      S100A4 involvement in metastasis: Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme

      CANCER RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 06:35:26